APA (7th ed.) Citation

MT, M., EL, S., WS, C., S, C., JA, C., & JH, F. (2026). Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors. Pediatric blood & cancer, 73(5), e70199. https://doi.org/10.1002/1545-5017.70199

Chicago Style (17th ed.) Citation

MT, McEvoy, Seashore EL, Cheng WS, Clay S, Casas JA, and Foster JH. "Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors." Pediatric Blood & Cancer 73, no. 5 (2026): e70199. https://doi.org/10.1002/1545-5017.70199.

MLA (9th ed.) Citation

MT, McEvoy, et al. "Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors." Pediatric Blood & Cancer, vol. 73, no. 5, 2026, p. e70199, https://doi.org/10.1002/1545-5017.70199.